0.9250
-0.0250
(-2.63%)
At close: 4:10:22 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
18,655.3830
18,655.3830
13,649.6450
11,963.7000
6,784.0510
Operating Income
-18,655.3830
-18,655.3830
-13,649.6450
-11,963.7000
-6,784.0510
Net Non Operating Interest Income Expense
832.5770
832.5770
591.8390
53.9150
18.8470
Other Income Expense
4,003.4700
4,003.4700
3,134.3810
707.8070
424.8850
Pretax Income
-13,819.3360
-13,819.3360
-9,923.4250
-11,201.9780
-6,340.3190
Net Income Common Stockholders
-13,819.3360
-13,819.3360
-9,923.4250
-11,201.9780
-6,340.3190
Basic EPS
-0.07
-0.08
-0.06
-0.07
-0.05
Diluted EPS
-0.07
-0.08
-0.06
-0.07
-0.05
Basic Average Shares
161,962.8240
164,500.7210
160,720.6480
153,309.8570
130,963.6950
Diluted Average Shares
161,962.8240
164,500.7210
160,720.6480
153,309.8570
130,963.6950
Net Income from Continuing & Discontinued Operation
-13,819.3360
-13,819.3360
-9,923.4250
-11,201.9780
-6,340.3190
Normalized Income
-13,819.3360
-13,819.3360
-9,923.4250
-11,201.9780
-6,340.3190
Interest Income
832.5770
832.5770
591.8390
53.9150
18.8470
Net Interest Income
832.5770
832.5770
591.8390
53.9150
18.8470
EBIT
-18,655.3830
-18,655.3830
-13,649.6450
-11,963.7000
-6,784.0510
EBITDA
-18,374.1870
-18,374.1870
-13,368.4490
-11,682.5040
-6,502.8550
Reconciled Depreciation
281.1960
281.1960
281.1960
281.1960
281.1960
Net Income from Continuing Operation Net Minority Interest
-13,819.3360
-13,819.3360
-9,923.4250
-11,201.9780
-6,340.3190
Normalized EBITDA
-18,374.1870
-18,374.1870
-13,368.4490
-11,682.5040
-6,502.8550
6/30/2021 - 7/13/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ILA.AX Island Pharmaceuticals Limited
0.1600
-3.03%
PTX.AX Prescient Therapeutics Limited
0.0450
+2.27%
ACR.AX Acrux Limited
0.0230
+4.55%
NUZ.AX Neurizon Therapeutics Limited
0.1200
+20.00%
ACW.AX Actinogen Medical Limited
0.0300
+3.45%
OPT.AX Opthea Limited
0.6000
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
CMB.AX Cambium Bio Limited
0.3000
0.00%